Swati Jaiswal

1.1k total citations
47 papers, 857 citations indexed

About

Swati Jaiswal is a scholar working on Molecular Biology, Immunology and Infectious Diseases. According to data from OpenAlex, Swati Jaiswal has authored 47 papers receiving a total of 857 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 9 papers in Immunology and 8 papers in Infectious Diseases. Recurrent topics in Swati Jaiswal's work include Tuberculosis Research and Epidemiology (6 papers), Research on Leishmaniasis Studies (4 papers) and Drug Transport and Resistance Mechanisms (4 papers). Swati Jaiswal is often cited by papers focused on Tuberculosis Research and Epidemiology (6 papers), Research on Leishmaniasis Studies (4 papers) and Drug Transport and Resistance Mechanisms (4 papers). Swati Jaiswal collaborates with scholars based in India, United States and United Kingdom. Swati Jaiswal's co-authors include Jawahar Lal, Abhisheak Sharma, Prashant Mishra, Mahendra Shukla, Mohd Yaseen Malik, Kalpesh Vaghasiya, Nagarjun Rangaraj, Anil Kumar Dwivedi, Abhishek Arya and Brahmeshwar Mishra and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Immunology and Biochemical and Biophysical Research Communications.

In The Last Decade

Swati Jaiswal

42 papers receiving 843 citations

Peers

Swati Jaiswal
Swati Jaiswal
Citations per year, relative to Swati Jaiswal Swati Jaiswal (= 1×) peers Santanu Kar Mahapatra

Countries citing papers authored by Swati Jaiswal

Since Specialization
Citations

This map shows the geographic impact of Swati Jaiswal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Swati Jaiswal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Swati Jaiswal more than expected).

Fields of papers citing papers by Swati Jaiswal

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Swati Jaiswal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Swati Jaiswal. The network helps show where Swati Jaiswal may publish in the future.

Co-authorship network of co-authors of Swati Jaiswal

This figure shows the co-authorship network connecting the top 25 collaborators of Swati Jaiswal. A scholar is included among the top collaborators of Swati Jaiswal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Swati Jaiswal. Swati Jaiswal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jaiswal, Swati, et al.. (2025). Unraveling the role of the immune landscape in tuberculosis granuloma. Tuberculosis. 152. 102615–102615.
2.
Jaiswal, Swati, et al.. (2024). Empirical review on handwritten Devanagari script recognition techniques using AI approaches. 2(2). 119–137. 1 indexed citations
3.
Jaiswal, Swati, et al.. (2023). Real-world application of physiologically based pharmacokinetic models in drug discovery. Drug Metabolism and Disposition. 53(1). 100015–100015. 8 indexed citations
4.
Jaiswal, Swati, et al.. (2023). An advanced deep learning model for maneuver prediction in real-time systems using alarming-based hunting optimization. International Journal of Advances in Intelligent Informatics. 9(2). 301–301. 1 indexed citations
5.
Jaiswal, Swati, et al.. (2023). Synthesis and validation of click-modified NOD1/2 agonists. Innate Immunity. 29(8). 186–200. 4 indexed citations
6.
Jaiswal, Swati, et al.. (2023). An Efficient Real Time Decision Making System for Autonomous Vehicle Using Timber Chased Wolf Optimization Based Ensemble Classifier. Journal of Engineering Science and Technology Review. 16(1). 75–84. 2 indexed citations
7.
Jaiswal, Swati, et al.. (2023). Exploring the role of the protein tyrosine kinase a (PtkA) in mycobacterial intracellular survival. Tuberculosis. 142. 102398–102398. 4 indexed citations
9.
Jaiswal, Swati & Kishore K. Srivastava. (2018). Protein tyrosine kinase A modulates intracellular survival of mycobacteria through Galectin 3. Biochemical and Biophysical Research Communications. 498(4). 884–890. 10 indexed citations
10.
Jaiswal, Swati, Abhisheak Sharma, Mahendra Shukla, & Jawahar Lal. (2017). Simultaneous LC–MS-MS Determination of Lopinavir and Rifabutin in Human Plasma. Journal of Chromatographic Science. 55(6). 617–624. 6 indexed citations
11.
Gupta, Sonal, Dhanaraju Mandalapu, Veenu Bala, et al.. (2016). Design, synthesis and biological profiling of aryl piperazine based scaffolds for the management of androgen sensitive prostatic disorders. MedChemComm. 7(11). 2111–2121. 6 indexed citations
12.
Shukla, Mahendra, Swati Jaiswal, Abhisheak Sharma, et al.. (2016). A combination of complexation and self-nanoemulsifying drug delivery system for enhancing oral bioavailability and anticancer efficacy of curcumin. Drug Development and Industrial Pharmacy. 43(5). 847–861. 62 indexed citations
13.
Jaiswal, Swati, Abhisheak Sharma, Mahendra Shukla, & Jawahar Lal. (2016). LC-Coupled Esi MS for Quantification of Miltefosine in Human and Hamster Plasma. Bioanalysis. 8(6). 533–545. 8 indexed citations
14.
Sharma, Abhisheak, Swati Jaiswal, Mahendra Shukla, et al.. (2015). HPLC–MS-MS Method Development and Validation of Antileishmanial Agent, S010-0269, in Hamster Serum. Journal of Chromatographic Science. 53(9). 1542–1548. 3 indexed citations
15.
Jaiswal, Swati, Abhisheak Sharma, Mahendra Shukla, & Jawahar Lal. (2015). Gender-related pharmacokinetics and bioavailability of a novel anticancer chalcone, cardamonin, in rats determined by liquid chromatography tandem mass spectrometry. Journal of Chromatography B. 986-987. 23–30. 15 indexed citations
16.
Shukla, Sanjeev K., Abhisheak Sharma, Swati Jaiswal, et al.. (2015). Identification of β-Amino alcohol grafted 1,4,5 trisubstituted 1,2,3-triazoles as potent antimalarial agents. European Journal of Medicinal Chemistry. 109. 187–198. 30 indexed citations
17.
Sharma, Abhisheak, Swati Jaiswal, Mahendra Shukla, Mohd Yaseen Malik, & Jawahar Lal. (2015). Rapid quantitative analysis of ormeloxifene and its active metabolite, 7-desmethyl ormeloxifene, in rat plasma using liquid chromatography-tandem mass spectrometry. Journal of Chromatography B. 997. 7–15. 4 indexed citations
18.
Jaiswal, Swati, Abhisheak Sharma, Mahendra Shukla, et al.. (2014). Novel pre-clinical methodologies for pharmacokinetic drug–drug interaction studies: spotlight on “humanized” animal models. Drug Metabolism Reviews. 46(4). 475–493. 30 indexed citations
19.
Chawla, Ruchi, Swati Jaiswal, & Brahmeshwar Mishra. (2013). Development and optimization of polymeric nanoparticles of antitubercular drugs using central composite factorial design*. Expert Opinion on Drug Delivery. 11(1). 31–43. 23 indexed citations
20.
Deshpande, Sachin, Swati Jaiswal, S. B. Katti, & Yenamandra S. Prabhakar. (2011). CoMFA and CoMSIA analysis of tetrahydroquinolines as potential antimalarial agents. SAR and QSAR in environmental research. 22(5-6). 473–488. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026